2024-Mar Hybrid Technology Hub and Oncosyne held a kickoff meeting initiating development of Oncosyne’s next-generation in vitro diagnostic test for pancreatic cancer. The aim is to start clinical studies later this year.
2024-Mar Hybrid Technology Hub and Oncosyne held a kickoff meeting initiating development of Oncosyne’s next-generation in vitro diagnostic test for pancreatic cancer. The aim is to start clinical studies later this year.